Below is the information acquired on SMITH & NEPHEW PLC, which is not yet included in our research perimeter.

To request an evaluation of this company and its inclusion in the OpenCorporation Ranking or if you have additional, different and more updated data than what is published in this OpenCorporation company card, please write to info@opencorporation.org so that our team may take it in account.

Last update 31 March 2022

Description of economic activities

Manufacture of irradiation, electromedical and electrotherapeutic equipment (NACE2 2660)

This company, with headquarters in London, UK, is engaged in global medical technology business, specialising in the manufacture of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management products. Its history dates back when Thomas John Smith founded a pharmaceutical chemist shop in Hull, England in 1856. The founder entered into a partnership with his nephew, Horacio Nelson Smith, to form Smith and Nephew in 1896. The company has four global business units--Orthopaedic Reconstruction, which offers the widest range of joint bearing services available including joint replacement systems for knees, hips and shoulders; Orthopaedic Trauma, which offers internal and external fixation products to help repair broken bones; Endoscopy or 'minimally invasive surgery', which allows surgeons to access, visualise, resect and repair damaged tissue more efficiently and effectively; and Advanced Wound Management, which produces and markets products for managing difficult-to-heal wounds and speeding up the healing process. It offers one thousand product ranges including Oxinum, Synergy Hip with Oxinium, Trigen, Peri-loc, Dyonics, BioRCI Bioresorbabale screws, Acticoat and Allevyn. It is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedic companies. Its business strategy is based on researching, developing, manufacturing and marketing technically innovative and advanced medical devices. Its three focus areas of cross-business research are novel bioresorbable polymers, tissue or cell engineering, and non-invasive stimulation.
  • SMITH & NEPHEW PLC

  • United Kingdom (GB)
  • Company type: Corporate
  • Parent company: N/A
  • Chief Executive Officer (CEO): Mr Roberto Quarta
  • CEO Total remuneration: 467.058,337
  • Website: www.smith-nephew.com

Financial data

Number of employees

N/A
18,581
18,030
16,681

Revenue 1

5
4
5
4

EBIT 1

524
268
740
770

EBITDA 1

1
726
1
1

1 numbers are in millions

  • RepRisk Indicator (last month):  16

Social dialog

  • Transnational Corporate Agreement (TCA): N/A
  • Global Framework Agreement (GFA): N/A
  • Societas Europaea (SE): N/A
  • Bangladesh Accord: N/A

European Works Councils

Standards and certifications

  • Global Compact: N/A
  • CDP (Carbon Disclosure Project): N/A
  • Modern Slavery Statement:
  • ww.smith-nephew.com/global/ass…
  • Transparency Index: N/A
  • SA8000 Social Accountability: N/A
  • Integrated report: N/A
  • ISO26000: N/A
  • OECD Guidelines:
  • Social Development Goals (SDGs): N/A

Global Reporting Initiative certification

  • Global Reporting Initiative standards: N/A
  • Global Reporting Initiative GRI G4: N/A

Other company declarations

  • Corporate Social Responsability:
    N/A
  • Accessibility: N/A

Other resources

Policies

  • Training policy: N/A
  • Policy to protect the right to health and safety in the workplaces where the company operates: N/A
  • Policy to protect the right to health and safety in the workplaces in the supply chain: N/A
  • Diversity policy: N/A

Universal declarations

Declarations and treaties recognised by the country where the company has its registered office

  • Universal Declaration of Human Rights:
  • European Convention on Human Rights (ECHR):
  • Charter of Fundamental Rights of CDFL Workers (Strasbourg Charter 1989):
  • Charter of Fundamental Rights of the European Union EU CFR (Nice Charter 2000):
  • Treaty on the Functioning of the European Union TFEU:
  • Registered office in an OECD country:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Directives applied in the company offices in EU 27

  • D. 80/987/EEC:
  • D. 89/391/EEC:
  • D. 98/59/EC:
  • D. 2000/43/EC:
  • D. 2000/78/EC:
  • D. 2001/23/EC:
  • Council D. 2001/86/EC:
  • D. 2002/14/EC:
  • D. 2002/73/EC:
  • Council D. 2003/72/EC:
  • EP and Council D. 2005/56/EC:
  • D. 2009/38/EC:
  • D. 2004/25/EC:
  • D. 2011/35/EU:

Presence in main rankings

  • Global 100 Most Sustainable Corporations: N/A
  • Global CSR Rep Trak 100: N/A
  • BrandZ Top 100 Most Valuable US Brands: N/A
  • The Worlds Best Multinational Workplaces: N/A
  • The Gartner Supply Chain Top 25: N/A
  • The Worlds Most Innovative Companies: N/A
  • The Diversity Inc Top 50 Companies: N/A
  • Best Global Websites: N/A
  • Green Ranking Global Top 500: N/A
  • Green Ranking Global Top 100: N/A

Reference trade unions